Poliovirus ts mutants were cultivatcd at a tcmperature (39.6 °) too high for their optimal growth but low enough to pcrmit full growth of the parental is+ strain. Tests for production of infectious RNA and serum-blocking antigcn showed a gradient of mutant productivity that corrcspondcd closely with an earlier physiological classification of these mutants. No mutant produced fully wild-type yields of either RNA or antigen. In general, group A mutants produced thc least RNA and antigcn (some yields being undetectable or < i % of ts ÷ values) while group D mutants produced the most (up to 88 % of ts+ RNA and 27"6 % of ts + antigen). Mutants of groups B and C produced intermediate yields. Six of the mutants (all that were classified belonging to groups A or B) convcrtcd thcir small yield of RNA and antigcn to infective virus with an efficiency not significantly different from that of wild-type virus. The rcmaindcr (thirteen mutants, most of those classified belonging to groups C or D) matured either or both their RNA and antigcn incfficicntly and accordingly cxhibitcd a dcfcct in some stagc of maturation or asscmbly.
INTRODUCTION
A preliminary analysis of type I poliovirus temperature-sensitive (ts) mutants in terms of three types of physiological defect divided the mutants into four classes (groups A to D; Cooper, Johnson & Garwes, I966) . Group A mutants possessed all three types of defect, namely defects in prevention of thymidine incorporation into cellular DNA (pti ÷ character), in prevention of phosphorus incorporation into fraction 3 of cellular RNA (ppi3 + character), and in production of antigen that could bind fluorescent antibody (a+ character). Group B mutants were only defective in the ppi3 + and the a+ characters, group C mutants were only defective in the a+ character, and group D mutants were not defective in any of the characters examined. These four characters therefore evinced a form of covariafion that was asymmetric. This paper reports a further examination of the mutants in terms of two more characters, namely the abilities to produce infective RNA and serum-blocking antigen at the restrictive temperature.
PBS at o ° and assayed in presence of 200 mg./ml, of guanidine carbonate for the surviving guanidine-resistant g/I4OO virus. A reaction time of 2o min. was a little less than the time required for complete neutralization of the challenge virus in the absence of blocking antigen; the serum used had a k value of 75"8. The fraction of surviving virus was calculated in terms of an identically treated sample of challenge virus in which antiserum and blocking antigen were replaced by PBS; the effect of the serum alone was measured in a tube in which blocking antigen was replaced by PBS.
Incorporation of 32P. When 32p was used to label RNA during virus growth, carrierfree [a2P]orthophosphate was added to the infected cell suspensions described above after 2½ hr incubation to give a final concentration of 25 #c/ml. of cell suspension. In order to reduce cellular RNA synthesis actinomycin D was included in the medium at a concentration of 0-o 3 #g./ml. After the usual phenol and ether extractions, the RNA was precipitated 3 times with ethanol and o-4 ml. placed on a 4 ml. sucrose gradient (9 to 3o %) in o.oi M-EDTA (pH 7"o). Following centrifugation for 41 hr at 35,ooo rev./min, in a Spinco SW 39 swing-out head, o.z ml. gradient fractions were collected into 2 ml. water and examined for optical density at 26o m# and for radioactivity on an end window counter.
Materials. The poliovirus type I antiserum (hyperimmune rabbit serum) was purchased from Microbiological Associates; 32p was received as I c/mg. orthophosphate from the Australian Atomic Energy Commission, Lucas Heights, Sydney.
RESULTS

Production of infectious RNA
Twenty-two poliovirus ts mutants described by Cooper et al. (I966) were tested for production of infectious RNA at 39-6 °. In these experiments (Table I) there was very little infectious RNA present I hr after infection, showing that RNA from uneclipsed input virus was almost completely destroyed by the illumination. There was no increase at the restrictive temperature in ts-2o RNA over the I hr value, but ts-22 and ts-28 RNA were significantly increased. However, all three mutants made much less RNA per infectious centre at the restrictive temperature than did ts +. Free virus in the supernatant fluid at the time of sampling was always < lO -4 of the input virus, < lO -2 of the infectious centres and < Io -3 of the total yields; RNA extraction efl~ciencies of ts + were about lO -4, and about 5o% of the cells formed infectious centres. Other controls showed that yields at both permissive and restrictive temperatures were either normal or reduced as expected, and that wild-type revertant virus comprised a negligible proportion (< 2 %) of the 'leak', amounting to < o'o5 p.f.u. per infectious centre. (The 'leak' is here defined as the mutant virus achieving multiplication at 39"6°.) Table I also shows production of serum-blocking antigen, which is discussed in the next section.
Production of infectious RNA by the remainder of the mutants was examined in a total of seven experiments like those summarized in Table I , each of which compared several mutants at one time with ts +. The same controls were included, except that determinations of the infectious RNA present after I hr incubation were only made for is-2, is-3, ts-I9, ts-Io4 and three ts + controls. However, these 'base-line' RNA values were all the same as those reported in Table I (standard units/ml.) Cells infected with light-sensitive mutant (ts +) stocks were diluted in medium, held at 37 ° or 39.6 ° and kept in darkness. After ½ hr Table 2 gives the results of representative ,~xamples of these experiments, listing the mutants in the order of their increasing ability to produce RNA under the restrictive conditions. The tests did not divide the mutants into sharply defined groups equivalent to completely defective or fully wild phenotypes. Instead, there was a gradation of RNA production values from almost nil to 88 % of wild-type values that did not correlate with the mutant's yield of mature virus expressed in relation either to ts + yields at 39"6 ° (col. 2) or to yield of mutant at 37 ° (not shown). Thirteen of the 2I mutants tested were each examined in at least two different experiments, which gave the same results. As examples of the variations encountered, in six separate experiments ts-28 produced between 2.I and 7"o 0/0, and in four experiments ts-22 produced between i2 and 26%, of ts + values at 39.6 °. 4"6 2"9 1"59 6"3 0"75 46 4"6 3"0 1-53 Relative mutant yield (col. 2) divided by relative RNA yield (col. 3). § Standard units of serum-blocking mutant antigen produced at 39-6 ° per '~infectious centre, expressed as a percentage of ts + antigen made at 39.6 ° per ts + infectious centre.
I[ Relative mutant yield (col. 2) divided by relative serum-blocking antigen yield (col. 5)-Two main facts are apparent from the RNA data given in Table 2 . First, three mutants produced no detectable new RNA at all at 39.6 °, the amounts found at 5 hr being not in excess of that to be expected from the input RNA surviving the irradiation procedure. Secondly, a comparison of RNA and mature virus production at 39.6 ° (expressed in Table 2 as a maturation efficiency, col. 4) indicates that some mutants converted their small yield of RNA to mature virus with an efficiency not significantly different from that of wild-type. These mutants were ts-8x, -28, -46, -Io4, -44, and -~5 o, and their maturation efficiencies were o'44 to I'73. The conclusions about maturation efficiency were always the same in repeated experiments. Maturation efficiency is meaningless for those mutants for which no new RNA was detectable, and these values are in parentheses to indicate this. The remainder of the mutants (is-99, -22, -89, -I9, -37, -3, -2, -I49, -38, -9, -I55 and -94) produced widely different amounts of RNA (3 to 88 % of ts +) but did not mature their RNA efficiently at 39"6 ° (maturation efficiency <~ o'I4), and can therefore be said to have some defect in maturation. and ts-28 at 39.6 °. The procedure was as described in Methods, except that the medium contained actinomycin D (0-03 #g./ml.) and z~P was added (to 25/~c/ml.) 2½ hr after inoculation, and the RNA extract was precipitated three times with ethanol. Equal portions of the final extracts were centrifuged for 4½ hr at 35,000 rev./min, through a 9 to 30 % sucrose gradient, and fractions of the gradient were analysed for ~2p (©__©) and optical density (--).
In some experiments, the amount of viral RNA produced was also measured in terms of s2p incorporation into 35 S RNA, as it was important to know whether the mutants produced a yield of viral RNA at 39"6 ° that was normal in amount but of low infectivity. The procedure was the same as for the other experiments except that the medium contained actinomycin D, andlabel was added 2½ hr after infection; the extract was precipitated three times with ethanol to remove inorganic phosphate. Figure I gives the results for ts +, ts-I 9 and ts-28, and shows that the amounts of 3~p incorporation into 35 S RNA for ts-I9 and -28 were much less than that for ts +, and were not significantly different from the values to be expected from the yields of infectious RNA shown in Table I (Io % and 2"9 °L, respectively, of ts+). It is thus unlikely that these mutants produce much vira] RNA in a non-infectious form at 39.6 °.
Characterization of the serum-blocking antigen test
The production by the mutants of antigen that would bind fluorescent antibody was measured by Cooper et al. (I966) in a qualitative test. A quantitative measure of the mutants' antigen in terms of ability to block neutralizing antibody was made in the present work by a method based on that of De Mars (I955), in which various dilutions of the unknown antigen were incubated with antiserum, and the residual free antibody was back-titrated by its ability to inactivate a standard amount of challenge virus. The procedure described in Methods represents the most sensitive adaptation to the present conditions. The use of the guanidine-resistant challenge strain g/I4oo enabled it to be titrated in presence of a large excess of guanidine sensitive virus. A 'standard antigen' was prepared, comprising a 7 hr (37 °) ts + culture preserved in small samples at -45° and given an arbitrary value of 640 standard antigen units/ml. All serum-blocking antigen was measured in terms of this standard antigen (Fig. 2) . The left-hand curve of Fig. 2 shows the relation between various dilutions of standard antigen and the logarithm of the surviving fraction of challenge virus when treated as described in Methods. In the absence of antigen, the titre of challenge virus was reduced to about o'5 %. With each assay of a batch of unknown antigens, a standard curve covering the most nearly linear portion was constructed; this comprised several dilutions of a fresh sample of standard antigen treated with antibody and challenged by the procedure described in Methods. The amounts of antigen produced by the mutants and their concurrent ts+ controls were read off the standard curve by means of their effect on the survival of g/I4OO. The smallest amount of antigen that could be measured by this method was about 2 standard antigen units, i.e. about 1% of ts + yields at 39"6 °. The amounts of antigen present in samples taken at I hr from one experiment involving six mutants and ts + incubated at 37 ° and 39-6 ° were all undetectable, i.e. < 2 standard units or < 1% of the 7 hr ts + value at 39.6 °. The reproducibility of the antigen estimation between assays was checked by including a single ts+ antigen preparation in five different assays. The mean titre was 355"2 standard units/ml., and the standard deviation was 55"8. The variation within an assay was checked by measuring nine identical replicates of standard antigen containing about nine standard units, a value falling within the lower linear portion of the standard curve from which most measurements were made. The mean value obtained was 8-72 standard units and the standard deviation was I'34. Some mutants produced very little antigen and had to be tested at very low dilutions. The large amounts of deoxycholate or cell debris in these assays may have interfered with the reaction of antigen with antibody. In order to test the effect of deoxycholate, this compound was added to about 9 standard units of antigen to final concentrations of 2, 0"7 and 0.2 mg./ml., but the antigen contents obtained on assay (8"9, 9"7 and Io'7 standard units respectively) were not significantly different from the untreated control value of 8"7. The effect of cell debris was checked by mixing an undiluted deoxycholate-treated preparation of ts-I55 grown at 39"6 ° with an equal volume of standard antigen containing about 9 units. The mixture when assayed contained I6"4 standard units, a value not significantly different from the sum of the values obtained in a concurrent assay of the separate components mixed with saline (8.7 units for the standard antigen and 8.8 units for the ts-I55 preparation). The ts-I55 preparation was also shown to have no direct inactivating effect on the challenge virus when mixed with it in absence of antibody.
Production of serum-blocking antigen
Tests for the production of serum-blocking antigen were done on samples from the same experiments in which infective RNA production was measured (see Table I above). The values obtained for production of RNA, mature virus and antigen by the mutants are therefore directly comparable. Table 2 gives the antigen values for the experiments presented for the remainder of the mutants, expressed (like the RNA and mature virus yields) in terms of relative yield per infective centre as compared with ts + yields.
None of the ts mutants tested produced fully wild-type amounts of serum-blocking antigen at 39-6 ° ( Table 2) . Most yields were in fact rather small, ranging from < 10/0 to 27.6% of ts + values. Eight of the I7 mutants tested were examined in at least two different experiments which gave the same results: for example, in three separate experiments ts-2 produced 27"6, I2"7 and 25.6%, and ts-28 produced 4"o, 6"3 and 4"3 0/0, of the ts + antigen values at 39.6 °. The significance of these figures can be seen more dearly in the relation of antigen production to infective yield as shown by the ' maturation efficiency' of the serum-blocking antigen (col. 6 of Table 2) ; low values of this parameter (~< o. 16) indicate some defect in the conversion of antigen to infective particles while values around I (o'47 to 1.7) show that the antigen made was efficiently matured. With one exception (see below) the conclusions with regard to maturation efficiency were always the same in repeated experiments. However, like the RNA RNA and antigen from poliovirus ts mutants 3o5 maturation efficiency, this, too, was meaningless unless new antigen could be shown to be produced (i.e. unless mutant antigen yields were > 1% of ts+ yields), and such uninterpretable values are again indicated by brackets. Where significant leak occurred, it was presumed that the antigen was newly made.
On these bases four of the mutants tested (ts-23, -I49, -38 and -37) did not produce any new serum-blocking antigen at 39.6 °, and so their maturation efficiencies could not be measured. Seven mutants (ts-28, -46, -IO4, -44, -I5 o, -3 and -I55 ) produced small amounts of antigen (2"5 to Io.r % of ts + yields) which they matured efficiently. Five mutants (ts-5, -9, -19, -22 and -2) also produced antigen (I.8 to 27.6 % of ts + yields) but were defective in the conversion of this antigen to infective virus. In the experiment of Table 2 , ts-2o apparently produced some new antigen by the criteria used, but a second experiment with a different inocuium failed to show production of new antigen, indicating that the antigen measured in the experiment of Table 2 probably represented inoculum material.
DISCUSSION
All of the ts mutants examined showed some defect in production of both infective RNA and serum-blocking antigen, as none gave fully wild-type yields of either product. The amount of RNA found ranged from 0"09 % to 88 % of ts + RNA, and there was an almost continuous gradient of values between these two extremes ( Table  2 ). This gradient might be regarded simply as an arrangement according to the 'leak' of infectious RNA synthesis, although this leak is not directly reflected in the mutants' ability to form mature virus. Such leak may reflect quantitative differences in efficiency of a particular gene function, or it may reflect qualitative differences in type of function, as it is possible that a totally defective function may still allow some RNA to be made with low efficiency. Much the same might be said for antigen production, except that in this case it is also possible that capsid protein(s) are made in a form that does not react with neutralizing antibody and would not be detected by the test used. Table 3 summarizes the present results in comparison with the three other genetic characters of the mutants described earlier (Cooper et aL I966) . Group A mutants produced either no or relatively little new RNA or antigen at 39"6 °, and one member (ts-8I) showed no defect in maturing its RNA. Another member (ts-2o) has since been shown to be defective in a function needed to make or maintain the double-stranded form of viral RNA. Mutants of group B produced small amounts of RNA and antigen, but (with the exception of ts-2z) none showed any defect in converting either RNA or antigen to infective virus. One member of group B (ts-28) has since been shown to be defective in a function needed to produce or maintain progeny RNA, or to free it from the replication complex (D. Stancek & P. D. Cooper, I967, unpublished results); ts-28 is not defective in formation of double-stranded RNA.
Twelve of the mutants (ts-99, -22, -I9, -37, -89, -2, -3, -9, -38, -94, -r49 and -I55) were defective in their RNA maturation efficiency, and all previously examined except ts-99 and ts-2z belonged to groups C and D. Such a defect presumably reflects a ts mutation in a gene determining a structural (virion) protein or other protein involved in assembly. Five mutants (ts-2, -5, -9, -I9 and -22) produced serum-blocking antigen but did not convert it efficiently into infective particles, providing additional evidence 20-2 ppi3, defective in prevention of phosphorus incorporation into fraction 3 cellular RNA; a, defective in production of antigen binding fluorescent antibody. t ~ of ts + : data from Table 2. ~: From the data of Table 2 in these cases for defects in structural or assembly proteins. The production of relatively large amounts of non-infective serum-blocking antigen by is-2 appears to confirm its production of antigen as determined by the qualitative fluorescent antibody test (Cooper et al. 1966) . Table 3 also reveals some correlation between the sequence obtained from an asymmetric covariation of the three previously determined genetic characters and the gradient of RNA production: in general, mutants of groups C and D make more RNA than those of group B, and mutants of group B make more than those of group A. It therefore seems feasible that this unusual type of covariation is simply a reflexion of the amount of RNA produced by the mutants. It might be expected that a small yield of RNA would reduce the quantities of gene products translated from progeny RNA if this can act as messenger, so that characters controlled by different genes may well be covariant if a defect in or repression of RNA synthesis exists. It may be noted, however, that this concept is not rigidly supported by the data of Table 3 . It remains possible that the gradient reflects the expression of various polar mutations in a single preceding gene, as has been reported for the lac and histidine operons of coliform bacteria (Jacob & Monod, I96I; Ames & Hartman, I963) , but there is no support for this idea in the shape of a corresponding gradient within the pti or the ppi3 values of the poliovirus mutants.
